Top oncology specialists across Holland, France and Sweden have formed a new alliance to improve cancer research and reduce treatment …
A court in Denmark has ruled in favour of Pfizer in challenges to patents on the active ingredient – atorvastatin …
Pfizer is to partner with American firm Medivation to develop and market a new drug for Alzheimer’s and Huntington’s disease.The …
Heart specialists have told patients to continue taking Schering-Plough and Merck's cholesterol-lowering drug Inergy, despite a study indicating that it …
Attention shifts from beta-amyloid to tau in the hunt for an Alzheimer's disease therapyIn years to come, scientists and pharmaceutical …
The 2008 edition of the ABPI Code of Practice came into force on 1 July and the industry is fairly …
Martin Dawkins is an Englishman born and bred, but has spent most of his career working abroad, including the US, …
Roche has been named and shamed in the medical press for breaching the ABPI's Code of Practice. Adverts about the …
Pfizer: changes in R&D structure expected to increase number of late stage productsPharmaceutical giant Pfizer has announced that it intends …
The first of a new kind of NHS allergy centre will be developed by North West SHA as part of …
Scotland's secondary schools will this week become the first in the UK to vaccinate female students against cervical cancer. It …
Stockholm-based specialty pharma company Meda has bought four of Roche’s pharma products in a deal worth 120 million Euros – …
The pharma industry has joined up with patient groups to petition for universal Hepatitis B immunisation for all children in …
Pfizer's smoking cessation drug Champix is the most effective pharmaceutical aid to quitting, according to new figures. A report on …